Twentyeight Health is a digital platform providing accessible and affordable reproductive and sexual healthcare through telemedicine consultations and at-home deliveries.

AOA Dx is a NYC-based company that has raised $17M in funding to develop a detection test for ovarian cancer using their GlycoLocate™ platform, which focuses on glycolipids and tumor marker gangliosides to improve early cancer detection.

Evvy is a precision women's health startup that provides comprehensive care through state-of-the-art testing and coaching, focusing on the vaginal microbiome to address misdiagnosis and recurrence rates associated with vaginal discomfort, and uncovering links to infertility, STIs, preterm birth, and gynecologic cancers.